A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA4 | hg19_v2_chr7_-_27169801_27169844 | -0.64 | 3.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_66918558 Show fit | 0.71 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3 |
|
chr5_-_56778635 Show fit | 0.67 |
ENST00000423391.1
|
actin, beta-like 2 |
|
chr9_-_3469181 Show fit | 0.55 |
ENST00000366116.2
|
Uncharacterized protein |
|
chr6_-_26235206 Show fit | 0.46 |
ENST00000244534.5
|
histone cluster 1, H1d |
|
chr10_-_92681033 Show fit | 0.40 |
ENST00000371697.3
|
ankyrin repeat domain 1 (cardiac muscle) |
|
chr3_-_64253655 Show fit | 0.35 |
ENST00000498162.1
|
prickle homolog 2 (Drosophila) |
|
chr11_+_128563652 Show fit | 0.34 |
ENST00000527786.2
|
Fli-1 proto-oncogene, ETS transcription factor |
|
chr19_+_45409011 Show fit | 0.28 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
apolipoprotein E |
|
chr18_-_56985873 Show fit | 0.25 |
ENST00000299721.3
|
complexin 4 |
|
chr12_+_72058130 Show fit | 0.24 |
ENST00000547843.1
|
THAP domain containing, apoptosis associated protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) regulation of Cdc42 protein signal transduction(GO:0032489) positive regulation of receptor catabolic process(GO:2000646) |
0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:1902725 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
0.0 | 0.2 | GO:0072099 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.0 | 0.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) negative regulation of amino acid transport(GO:0051956) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |